slots fortune legit
NoneThe Latest: Former President Jimmy Carter is Dead at age 100Why SIGA Technologies (SIGA) Is One of the Most Profitable Pharmaceutical Stocks Right Now?
The Atlanta Falcons drafting of Michael Penix Jr. just six weeks after signing Kirk Cousins to a $180 million contract doesn't seem like that much of a head-scratcher anymore. Penix, the eighth overall pick in this year's draft, was supposed to serve as Cousins' understudy for a year or two, a plan that was scuttled when Cousins quickly lost the zip and accuracy on his passes and his grip on the starting job. It was hard to argue with making the change after Cousins had nine picks and one touchdown pass in his last five starts — but it was a daring move nonetheless with the Falcons trailing first-place Tampa Bay by a single game with three weeks left. Penix made the move pay off with a solid first NFL start in the Falcons' 34-7 rout of the New York Giants on Sunday that bolstered Atlanta's playoff hopes , and the Falcons (8-7) moved back into first place in the NFC South with the Buccaneers' loss at Dallas on Sunday night. The left-hander was not at all overwhelmed by the moment, completing 18 of 27 passes for 202 yards — numbers that would’ve been better if not for at least three dropped passes, one of which Kyle Pitts bobbled right into the hands of a New York defender for Penix’s lone interception. “He went out and played almost flawless football,” coach Raheem Morris said. Cousins will almost certainly be looking for his fourth team in 2025. If the Falcons cut ties as expected, they'll have paid Cousins $90 million for 14 games. Cousins' career earnings are about $321 million and his record is 84-77-2, including a 1-3 mark in the playoffs and 7-7 this season. In the spirit of expedited judgments, let's take a gander at how other quarterbacks have fared with their new teams in 2024. The Pittsburgh Steelers landed the biggest bargain of the season in Wilson, whom they signed for the veteran's minimum of $1.21 million, leaving his former team, the Denver Broncos, on the hook for the remaining $37.79 million of his 2024 salary. Wilson's calf injury in camp forced the Steelers to start Justin Fields, who went 4-2 before Mike Tomlin made the risky switch to Wilson, who's gone 6-3 with 15 TD throws and four interceptions. With the Steelers (10-5) playoff-bound, Wilson will make his first postseason appearance since 2020. The only question is whether it'll be at home as AFC North champ or on the road as a wild-card. They're tied with the Ravens atop the division but currently own the tiebreaker. This was expected to be a rebuilding year in Minnesota after the Vikings lost Cousins in free agency. They signed Darnold, the third overall pick in 2018, to a $10 million, one-year contract and drafted national champion J.J. McCarthy with the 10th overall pick. McCarthy tore the meniscus in his right knee during the preseason opener and has undergone two surgeries, opening the way for Darnold's breakthrough season. Darnold brought a 21-35 career record with him to Minneapolis and all he's done is go 13-2 while setting career highs with 32 touchdown passes, 3,776 passing yards and a 67.2% completion percentage. The Vikings are tied with the Lions atop the packed NFC North and the division crown could come down to Minnesota's season finale at Detroit on Jan. 5. The Las Vegas Raiders signed Minshew to a two-year, $25 million contract and he beat out incumbent Aidan O'Connell for the starting gig. But he only went 2-7 and sustained a season-ending broken collarbone in a Week 12 loss to the Broncos, opening the door for O'Connell (1-4) to return. The Raiders' 19-14 win over Jacksonville on Sunday snapped a 10-game skid but might have taken them out of the Shedeur Sanders sweepstakes. They are 3-12, a game behind the Giants (2-13), who jettisoned QB Daniel Jones less than two years after signing him to a four-year, $160 million contract and have gone with Drew Lock and Tommy DeVito instead. The Chicago Bears had high hopes after drafting Williams with the No. 1 overall pick, but it might turn out that the second QB taken — Washington's Jayden Daniels — is better than the first as was the case last year when C.J. Stroud outperformed Carolina's Bryce Young. Williams has a terrific TD-to-INT ratio of 19-5, but the Bears are 4-11 and have lost nine in a row. Their last win came way back on Oct. 13 against Jacksonville. The 2023 Heisman Trophy winner out of LSU has led the Washington Commanders (10-5) to the cusp of their first playoff appearance since 2020. His bolstered his Rookie of the Year credentials with a five-TD performance Sunday in leading the Commanders to a 36-33 win over the Philadelphia Eagles. For the year, Daniels has 22 TD throws and eight interceptions. The former Auburn and Oregon star hasn't looked much like a rookie after starting an NCAA QB record 61 times in college. The Broncos (9-6) could snap an eight-year playoff drought with a win Sunday at Cincinnati thanks to Nix's steady play , Sean Payton's exhaustive guidance and Denver's traditionally stingy defense. Nix was drafted 12th overall after the Broncos released Wilson despite a a whopping $85 million dead money charge on top of the $37.79 million they're paying Wilson to play for Pittsburgh this year. With 22 TDs and 11 interceptions, Nix has almost matched Russell's win total (11-19) in his two seasons in Denver. AP Sports Writer Paul Newberry in Atlanta contributed to this report. Behind the Call analyzes the biggest topics in the NFL during the season. AP NFL: https://apnews.com/hub/nfl
( MENAFN - The Rio Times) Brazilian bus manufacturer Marcopolo has acquired a 40% stake in Chilean innovator Reborn Electric Motors for $4 million. This strategic investment aims to capture a significant share of Latin America's growing electric bus market. Reborn, founded in 2019, has already made headlines by producing the first electric bus to operate in Antarctica. This achievement aligns with Marcopolo 's goal to lead in sustainable transport solutions across the continent. The timing is opportune. Latin America's electric bus market is projected to grow by 15% annually until 2025. Currently, 5,900 electric buses operate in 41 cities across the region, with Chile leading at 2,659 units. Marcopolo's strong financials support this move. In Q3 2024, the company reported a net profit of R$335.7 million ($54 million), a 107.6% year-over-year increase. Their EBITDA reached R$466.0 million ($75 million), showing robust operational performance. This partnership positions Marcopolo to compete with established players like BYD , Foton, and Yutong in Latin America. By combining Marcopolo's manufacturing prowess with Reborn's innovative technology, the duo aims to accelerate eco-friendly public transportation adoption across the continent. As Latin American cities prioritize reducing emissions and improving air quality, Marcopolo's investment in Reborn could prove crucial. This move not only promises financial returns but also contributes to a cleaner, more sustainable future for urban transportation in the region. MENAFN24122024007421016031ID1109028378 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.Elon Musk’s preschool is the next step in his anti-woke education dreams
Manitoba Premier Wab Kinew's popularity shows little sign of waning more than a year after he led the provincial New Democrats to power. But there are some tough choices ahead as he tries to fulfil promises to improve health care, address poverty and get the government's finances in order. Kinew has carried through on election promises to hire more health-care workers, expand school nutrition programs and temporarily suspend the provincial fuel tax for a one-year period that is to end Jan. 1. The NDP government has also announced extra funding for the arts, policing and other items. Opinion polls continue to rank highly the NDP as a party and Kinew as a premier. What Kinew has yet to show is a plan to control spending in order to balance the budget by 2027 -- another campaign promise -- and end a long series of deficits in Manitoba, said political analyst Paul Thomas. "At some point, you have to make hard choices," said Thomas, professor emeritus of political studies at the University of Manitoba. "You don't get to continue to say yes to most requests that come along." In a year-end interview with The Canadian Press, Kinew said he's working on ways to add front-line staff to health care while finding cost savings elsewhere. The Health, Seniors and Long-Term Care ministry -- by far the biggest-spending government department -- was allocated hundreds of millions of more dollars in this year's budget to boost staffing levels and add hospital beds. A mid-year fiscal update earlier this month said the department was on track to spend even more and run $438 million over budget. "I think it's important for us to keep that flexibility with health spending right now because we are trying to match the needs of the health-care system to the population," Kinew said. "A lot of what we're doing right now is trying to get through this transitional period of scaling up health care to the appropriate size." When pressed for specifics on where the government is cutting costs, Kinew hinted there was guidance being given to some departments. "We are looking at making sure that the belt tightening that we do is more like, 'Do you really need that software subscription? Does the lobby really need a new coat of paint in someone's office?"' Kinew said. "Things like that, which individually are smaller-scale decisions, but over an apparatus the size of the provincial government ... it does total tens of millions of dollars." The latest deficit projection for the current fiscal year is $1.3 billion -- $513 million higher than the original budget projection. The government will face new spending requirements as it ramps up, among other initiatives, new programs to tackle homelessness. Kinew is a gifted public speaker and communicator who connects with the public as empathetic and caring, Thomas said. The premier also uses social media well and his New Democrats often set up news conferences in community settings where supporters and funding recipients are in attendance and applauding. The New Democrats are also helped by the state of the Opposition Progressive Conservatives, who are still working to rebuild after losing the last election and are under an interim leader until their convention slated for April, Thomas added. Kinew's public missteps have been few so far, and Thomas said the premier has moved quickly to address them before controversy can grow. Kinew came under fire in September after Mark Wasyliw was removed from the NDP caucus. Kinew said it was because Wasyliw's former law partner was representing convicted sex offender Peter Nygard. The legal community said the premier was attacking the role defence lawyers play in the justice system. Kinew apologized and the New Democrats cited other reasons for Wasyliw's dismissal. The NDP also backtracked quickly in the spring after initially cutting funding for "green team" youth summer jobs. Many community groups denounced the move, and funding was partially restored. "Issues have come and gone, but it hasn't dented (the NDP's) image and reputation," Thomas said. This report by The Canadian Press was first published Dec. 24, 2024.
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo® Rapid TP/HIV Test (Multiplo® TP/HIV) to be rolled out across Canada, a critical point-of-care tool to address the health crises with HIV and syphilis in Canada. The single Reveal® TP (Syphilis) approval will follow soon after this more complex approval. The Multiplo® TP/HIV rapid test allows healthcare professional to accurately detect both HIV-1/2 and syphilis antibodieswith one sample using a simple finger prick that delivers results immediately. This easy-to-use and high-quality test can be used in any setting and does not need any special storage conditions. Making it the perfect solution for use in hospitals, doctor's offices and other settings and provides another important option in the Canadian market to help people know their status and get connected to treatment and care. "Our Multiplo® TP/HIV device is the fastest testing solutions for HIV-1/2 and Syphilis and has been used in various settings and markets (such as in Europe, Colombia etc) for years. The Health Canada Medical Device License for professional-use will immediately address critical gaps in healthcare settings at a fraction of the costs of conventional testing systems," said Hermes Chan, CEO of MedMira, a world leader in developing rapid diagnostics and technologies. "Together with REACH Nexus we aim to supply urban and remote communities across Canada, and with it provide access to a critical needed screening tool. This test will have a significant impact on the already stretched and overburdened health care system by providing a fast and cost-efficient screening method." Health Canada's licensure of the device is based on the results of a landmark clinical study in Alberta, co-led by Dr. Sean B. Rourke, director of REACH Nexus and a scientist with the MAP Centre for Urban Health Solutions at St. Michael's Hospital (Unity Health Toronto) and Dr. Ameeta Singh at the University of Alberta. "We urgently need more rapid testing options approved in Canada to reach the undiagnosed with HIV, syphilis and other blood-borne infections and sexually transmitted infections (STBBIs)," said Dr. Rourke, the director of REACH Nexus at MAP. "We are very excited about this ongoing partnership with MedMira and the critical implementation science work that went into getting this device approved and into the hands of healthcare professionals." Health Canada's approval of the Multiplo® TP/HIV rapid test couldn't come at a more urgent time. The latest data from the Public Health Agency of Canada, shows that new HIV diagnoses soared more than 35% from 2022 to 2023, with rates in Manitoba rising by more than 40%. In Saskatchewan, the rate of HIV was 19.4 per 100,000 people, more than three times the national rate. In 2022, there were 13,953 reported syphilis cases, with rates increasing by 109% compared to 2018, and with congenital syphilis cases seeing a 7% increase from 2021 and a 599% increase from 2018(1). With the rising cases, particularly in underserved and remote communities, the Multiplo® TP/HIV provides an essential testing device to help reach the undiagnosed living with HIV and/or syphilis. "These tests are essential amid the rising number of STBBIs and will have real-life impacts," said Dr. Rourke. "Not everyone has access to the testing they need for STBBIs because of health inequities, stigma and various forms of discrimination. MedMira's rapid test is a crucial tool in Canada - so everyone can have access to the testing they need." As part of Health Canada's review and authorization process, Dr. Rourke's team of researchers sourced funding and conducted the landmark studyworking closely with healthcare providers, provincial health ministry and laboratory agencies, community stakeholders, and people with lived experience. The study, conducted from 2020-2022, included over 1,500 participants from clinical settings in Edmonton and northern Alberta. The study found the Multiplo® TP/HIV test to be 100 per cent accurate in identifying HIV infection, and more than 98 per cent accurate in detecting syphilis. "Having more HIV rapid tests increases our chances of reaching people in Canada who have HIV and don't know it, and a very significant and increasing number of infectious and congenital syphilis cases" said Dr. Rourke. "This rapid, accessible test helps breakdown barriers that some people face so they can get tested so they know their status. It helps move closer to ending the HIV and syphilis epidemics in Canada." (1) https://www.canada.ca/en/public-health/services/publications/diseases-conditions/hiv-canada-surveillance-report-december-31-2022.html About REACH Nexus at MAP Centre for Urban Health Solutions REACH Nexus is an ambitious national research group working on how to address HIV, Hepatitis C, and other sexually transmitted and blood-borne infections (STBBIs) in Canada. Their focus is on reaching the undiagnosed, implementing and scaling up new testing options, strengthening connections to care, improving access to options for prevention (PrEP and PEP) and ending stigma. We work in collaboration and partnership with people living with HIV; community-based organizations; front-line service providers; healthcare providers and decision makers; public health agencies; researchers; business leaders; industry partners, and federal, provincial and regional policymakers.REACH Nexus is part of MAP Centre for Urban Health Solutions at St. Michael's Hospital, Unity Health Toronto, and is funded by the Canadian Institutes of Health Research. Follow us on Twitter, Instagram and Facebook. About MedMira MedMira is a leading developer and manufacturer of Rapid Vertical Flow® diagnostics. The Company's tests provide hospitals, labs, clinics, and individuals with instant disease diagnosis, such as HIV, Syphilis, Hepatitis, and SARS-CoV-2, in just three easy steps. The Company's tests are sold globally under the REVEAL®, REVEALCOVID-19®, Multiplo® and Miriad® brands. Based on its patented Rapid Vertical Flow® Technology, MedMira's rapid HIV test is the only one in the world to achieve regulatory approvals in Canada, the United States, China and the European Union. MedMira's corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada. For more information visit medmira.com . Follow us on Twitter and LinkedIn . This news release contains forward‐looking statements, which involve risk and uncertainties and reflect the Company's current expectation regarding future events, including statements regarding possible regulatory approval, product launch, future growth, and new business opportunities. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. MedMira Contact Markus Meile Chief Financial Officer MedMira Inc. ir@medmira.com REACH Nexus Contact Andrew Russell Senior Communications Specialist REACH Nexus - MAP Centre for Urban Health Solutions andrew.russell@unityhealth.to SOURCE: MedMira Inc. View the original on accesswire.com
Donkey named Wonder gets new prosthetic leg for Christmas